J
Joel W. Greer
Researcher at Centers for Medicare and Medicaid Services
Publications - 31
Citations - 22967
Joel W. Greer is an academic researcher from Centers for Medicare and Medicaid Services. The author has contributed to research in topics: Dialysis & End stage renal disease. The author has an hindex of 21, co-authored 31 publications receiving 22395 citations. Previous affiliations of Joel W. Greer include Cornell University & United States Department of Health and Human Services.
Papers
More filters
Journal Article
Trends in use, cost, and outcomes of human recombinant erythropoietin, 1989-98.
TL;DR: In this paper, the authors present descriptive data showing trends in human recombinant erythropoietin (EPO) doses, charges, and patient hematocrits from the fourth quarter of calendar year 1989 to the first quarter of 1998 for all recipients and recent data for patients treated by in-center hemodialysis.
Journal ArticleDOI
Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service
Paul W. Eggers,Diane L. Frankenfield,Joel W. Greer,William M. McClellan,William F. Owen,Michael V. Rocco +5 more
TL;DR: Care by HMO for patients with an expensive chronic illness can achieve outcomes similar to those for FFS patients, and an argument used to justify continued prohibition against widespread participation by patients with ESRD is not supported.
Journal Article
A review of the first year of Medicare coverage of erythropoietin.
Robert I. Griffiths,Neil R. Powe,Joel W. Greer,G de Lissovoy,Gerard F. Anderson,Paul K. Whelton,Alan Watson,Paul W. Eggers +7 more
TL;DR: Dosing of rHuEPO and achieved hematocrit were lower than expected based on the results of clinical trials and the analysis of insurance claims data allowed effective monitoring of access, costs, and effectiveness of this new biotechnology.
Journal ArticleDOI
The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states
TL;DR: It is concluded that the Medicaid-only ESRD population excluded from Medicare coverage is particularly vulnerable to cost-containment measures that focus on expensive technologies such as rHuEPO.
Journal ArticleDOI
Introduction to the 1998 Annual Data Report of the United States Renal Data System
Robert A. Wolfe,Friedrich K. Port,Randall L. Webb,Wendy E. Bloembergen,Richard A. Hirth,Eric W. Young,Akinlolu O. Ojo,Robert L. Strawderman,Brenda W. Gillespie,Philip J. Held,Rulan S. Parekh,Austin G. Stack,Philip J. Tedeschi,Elizabeth Loos,Tempie E. Hulbert-Shearon,Valarie B. Ashby,Sandra Callard,Sean M. Orzol,Caitlin C. Carroll,John Wheeler,Camille A. Jones,Pamela R. Frederick,Joel W. Greer,Lawrence Y. Agodoa +23 more